
Background: Deep brain stimulation is an approved therapy for essential tremor and Parkinson’s disease. In addition, VIM-DBS is used off-label for the treatment of tremor syndromes with a different etiology.
Case Report: We present the case of a woman with a drug-refractory action tremor due to rare compound heterozygous POLR3A mutations. Her treatment with VIM DBS did not lead to a sustained improvement of symptoms.
Discussion: Tremor due to POLR3A-related cerebellar syndromes may not be responsive to VIM DBS. The networks contributing to cerebellar tremor should be better investigated in terms of where neuromodulatory therapy might be more effective.
© 2025 Ute Scheller, Steffen Paschen, Fabian Maass, Christoph van Riesen, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.